Registered entities
INTELLIA THERAPEUTICS, INC.
Reg. No. 1652130United States
Intellia Therapeutics, Inc
Reg. No. 36-4785571Belgium
Social engagement
Social engagement: 71.9K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; lead investors include Orbimed, Atlas Venture, Novartis.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 50% |
| Private equity | 2 | 17% |
| Other / undisclosed | 4 | 33% |
Hiring activity
Hires frequently
9 roles tracked across 6 of the last 12 months
10 Jun 2026 · Associate Director, Regulatory Affairs, Advertising, Promotion Labeling (RA-APL) · Cambridge
10 Jun 2026 · Director, Strategic Account Liaison · Cambridge
31 Mar 2026 · Director, Healthcare Compliance · Cambridge
22 Jan 2026 · Executive Assistant · Cambridge
17 Dec 2025 · Associate Director Data Architect · Cambridge
Based on job postings tracked across public sources.
Recent activity
10 Jun 2026
Event
Peripheral Nerve Society Annual Meeting
1 Jun 2026
Event
European Academy of Allergy and Clinical Immunology - EAACI Congress
28 May 2026
Event
Eastern Allergy Conference